Status:
COMPLETED
A Pharmacovigilance Study of Torsade de Pointes
Lead Sponsor:
University of Peshawar
Conditions:
Torsades de Pointe Caused by Drug
Eligibility:
All Genders
Brief Summary
Many cardiac and non-cardiac drugs are associated with TdP that may constitute a significant problem because of sudden cardiac death. This study aims to present a comprehensive overview and disproport...
Detailed Description
Drug-induced Torsade de Pointes (TdP) is a serious but an overlooked adverse drug reaction because a wide range of marketed drugs associated with TdP are commonly prescribed in routine practice. Owing...
Eligibility Criteria
Inclusion
- TdP cases reported in the FAERS database till 31/03/2019
- Adverse event reported was including the MedDRA term: Torsade de Pointes
Exclusion
- Drugs with less than 10 TdP reports
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
6670 Patients enrolled
Trial Details
Trial ID
NCT04293432
Start Date
May 15 2019
End Date
January 1 2020
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacy, University of Peshawar
Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000